Schrodinger, Inc. $SDGR Shares Purchased by Geneos Wealth Management Inc.

Key Points

• Geneos Wealth Management Inc. increased its stake in Schrodinger, Inc. by 41.6% during the first quarter, now owning 84,943 shares valued at approximately $1.68 million.
• Schrodinger reported an earnings per share (EPS) of ($0.59) for the last quarter, exceeding analysts' expectations of ($0.83), with revenue rising 15.7% year-over-year.
• Analysts have mixed ratings on Schrodinger's stock, with a consensus target price of $27.83, and noted a decrease in target prices from several major firms.

Geneos Wealth Management Inc. lifted its position in shares of Schrodinger, Inc. (NASDAQ:SDGR - Free Report) by 41.6% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 84,943 shares of the company's stock after acquiring an additional 24,947 shares during the quarter. Geneos Wealth Management Inc. owned approximately 0.12% of Schrodinger worth $1,677,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Northern Trust Corp grew its position in Schrodinger by 11.3% during the fourth quarter. Northern Trust Corp now owns 602,618 shares of the company's stock worth $11,625,000 after buying an additional 60,987 shares in the last quarter. BNP Paribas Financial Markets purchased a new position in shares of Schrodinger during the 4th quarter valued at about $330,000. Captrust Financial Advisors purchased a new position in shares of Schrodinger during the 4th quarter valued at about $240,000. Deutsche Bank AG raised its holdings in shares of Schrodinger by 8.2% during the 4th quarter. Deutsche Bank AG now owns 233,026 shares of the company's stock valued at $4,495,000 after buying an additional 17,700 shares in the last quarter. Finally, Ensign Peak Advisors Inc raised its holdings in shares of Schrodinger by 7.3% during the 4th quarter. Ensign Peak Advisors Inc now owns 25,643 shares of the company's stock valued at $495,000 after buying an additional 1,750 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Analysts Set New Price Targets

SDGR has been the subject of several research analyst reports. Wall Street Zen cut Schrodinger from a "hold" rating to a "sell" rating in a report on Saturday, August 30th. Morgan Stanley dropped their price target on shares of Schrodinger from $28.00 to $19.00 and set an "equal weight" rating for the company in a research report on Monday, August 18th. KeyCorp dropped their price objective on shares of Schrodinger from $32.00 to $30.00 and set an "overweight" rating for the company in a research note on Monday, July 14th. Citigroup cut Schrodinger from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $35.00 to $20.00 in a report on Friday, August 15th. Finally, Barclays started coverage on Schrodinger in a research report on Thursday, August 14th. They set an "overweight" rating and a $25.00 target price for the company. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $27.83.

Schrodinger Price Performance

NASDAQ:SDGR traded down $0.11 during midday trading on Monday, hitting $18.46. The company's stock had a trading volume of 802,398 shares, compared to its average volume of 1,147,586. The firm's 50 day moving average is $20.22 and its 200-day moving average is $21.62. The firm has a market cap of $1.36 billion, a P/E ratio of -7.44 and a beta of 1.79. Schrodinger, Inc. has a fifty-two week low of $16.60 and a fifty-two week high of $28.47.

Schrodinger (NASDAQ:SDGR - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.59) earnings per share for the quarter, beating analysts' consensus estimates of ($0.83) by $0.24. The business had revenue of $54.76 million during the quarter, compared to analyst estimates of $52.03 million. Schrodinger had a negative return on equity of 45.70% and a negative net margin of 76.22%.The company's revenue was up 15.7% on a year-over-year basis. During the same quarter last year, the business posted ($0.66) EPS. As a group, analysts forecast that Schrodinger, Inc. will post -2.37 EPS for the current year.

Schrodinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.